+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Non-Small Cell Lung Cancer Market and Competitive Landscape - 2020

  • ID: 5023478
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Non-Small Cell Lung Cancer Market and Competitive Landscape - 2020, provides comprehensive insights into the Non-Small Cell Lung Cancer pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Non-Small Cell Lung Cancer market size and drug sales. It also provides insights into Non-Small Cell Lung Cancer epidemiology and late stage pipeline.

This research covers the following: Non-Small Cell Lung Cancer treatment options, Non-Small Cell Lung Cancer late stage clinical trials pipeline, Non-Small Cell Lung Cancer prevalence by countries, Non-Small Cell Lung Cancer market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Non-Small Cell Lung Cancer pipeline: Find out drugs in clinical trials for the treatment of Non-Small Cell Lung Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Non-Small Cell Lung Cancer epidemiology: Find out the number of patients diagnosed (prevalence) with Non-Small Cell Lung Cancer by countries
  • Non-Small Cell Lung Cancer drugs: Identify key drugs marketed and prescribed for Non-Small Cell Lung Cancer in the US, including trade name, molecule name, and company
  • Non-Small Cell Lung Cancer drugs sales: Find out the sales value for Non-Small Cell Lung Cancer drugs by countries
  • Non-Small Cell Lung Cancer market valuations: Find out the market size for Non-Small Cell Lung Cancer drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Non-Small Cell Lung Cancer drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Non-Small Cell Lung Cancer drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Non-Small Cell Lung Cancer market
  • Develop in-depth knowledge of competition and markets
  • Analyze Non-Small Cell Lung Cancer drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Non-Small Cell Lung Cancer market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Non-Small Cell Lung Cancer Treatment Options

2. Non-Small Cell Lung Cancer Pipeline Insights
2.1. Non-Small Cell Lung Cancer Phase 3 Clinical Trials
2.2. Non-Small Cell Lung Cancer Phase 2 Clinical Trials
2.3. Non-Small Cell Lung Cancer Phase 1 Clinical Trials

3. Non-Small Cell Lung Cancer Epidemiology Analysis by Countries

4. US Non-Small Cell Lung Cancer Market Insights
4.1. Marketed Drugs for Non-Small Cell Lung Cancer in US
4.2. US Non-Small Cell Lung Cancer Market Size & Forecast
4.3. US Non-Small Cell Lung Cancer Drugs Sales & Forecast
4.4. US Non-Small Cell Lung Cancer Market Share Analysis

5. Germany Non-Small Cell Lung Cancer Market Insights
5.1. Marketed Drugs for Non-Small Cell Lung Cancer in Germany
5.2. Germany Non-Small Cell Lung Cancer Market Size & Forecast
5.3. Germany Non-Small Cell Lung Cancer Drugs Sales Forecast
5.4. Germany Non-Small Cell Lung Cancer Market Share Analysis

6. France Non-Small Cell Lung Cancer Market Insights
6.1. Marketed Drugs for Non-Small Cell Lung Cancer in France
6.2. France Non-Small Cell Lung Cancer Market Size & Forecast
6.3. France Non-Small Cell Lung Cancer Product Sales Forecast
6.4. France Non-Small Cell Lung Cancer Market Share Analysis

7. Italy Non-Small Cell Lung Cancer Market Insights
7.1. Marketed Drugs for Non-Small Cell Lung Cancer in Italy
7.2. Italy Non-Small Cell Lung Cancer Market Size & Forecast
7.3. Italy Non-Small Cell Lung Cancer Product Sales Forecast
7.4. Italy Non-Small Cell Lung Cancer Market Share Analysis

8. Spain Non-Small Cell Lung Cancer Market Insights
8.1. Marketed Drugs for Non-Small Cell Lung Cancer in Spain
8.2. Spain Non-Small Cell Lung Cancer Market Size & Forecast
8.3. Spain Non-Small Cell Lung Cancer Product Sales Forecast
8.4. Spain Non-Small Cell Lung Cancer Market Share Analysis

9. UK Non-Small Cell Lung Cancer Market Insights
9.1. Marketed Drugs for Non-Small Cell Lung Cancer in UK
9.2. UK Non-Small Cell Lung Cancer Market Size & Forecast
9.3. UK Non-Small Cell Lung Cancer Product Sales Forecast
9.4. UK Non-Small Cell Lung Cancer Market Share Analysis

10. Europe Non-Small Cell Lung Cancer Market Insights
10.1. Europe Non-Small Cell Lung Cancer Market Size & Forecast
10.2. Europe Non-Small Cell Lung Cancer Product Sales Forecast
10.3. Europe Non-Small Cell Lung Cancer Market Share Analysis

11. Japan Non-Small Cell Lung Cancer Market Insights
11.1. Marketed Drugs for Non-Small Cell Lung Cancer in Japan
11.2. Japan Non-Small Cell Lung Cancer Market Size & Forecast
11.3. Japan Non-Small Cell Lung Cancer Product Sales Forecast
11.4. Japan Non-Small Cell Lung Cancer Market Share Analysis

12. Global Non-Small Cell Lung Cancer Market Insights
12.1. Global Non-Small Cell Lung Cancer Market Size & Forecast
12.2. Global Non-Small Cell Lung Cancer Product Sales Forecast
12.3. Global Non-Small Cell Lung Cancer Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Non-Small Cell Lung Cancer Phase 3 Clinical Trials, Global, 2020
Table 2: Non-Small Cell Lung Cancer Phase 2 Clinical Trials, Global, 2020
Table 3: Non-Small Cell Lung Cancer Phase 1 Clinical Trials, Global, 2020
Table 4: Non-Small Cell Lung Cancer Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Non-Small Cell Lung Cancer in US, 2019
Table 6: US Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 8: US Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Non-Small Cell Lung Cancer in Germany, 2019
Table 10: Germany Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 12: Germany Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Non-Small Cell Lung Cancer in France, 2019
Table 14: France Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 16: France Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Non-Small Cell Lung Cancer in Italy, 2019
Table 18: Italy Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 20: Italy Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Non-Small Cell Lung Cancer in Spain, 2019
Table 22: Spain Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 24: Spain Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Non-Small Cell Lung Cancer in UK, 2019
Table 26: UK Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 28: UK Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 29: Europe Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Non-Small Cell Lung Cancer in Japan, 2019
Table 32: Japan Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Table 34: Japan Non-Small Cell Lung Cancer Market Events and Trends, 2016 - 2024
Table 35: Global Non-Small Cell Lung Cancer Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Non-Small Cell Lung Cancer Pipeline by Phase (%), Global, 2020
Figure 2: Non-Small Cell Lung Cancer Prevalence by Countries, 2016 - 2024
Figure 3: US Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 4: US Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 5: US Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 6: US Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 7: Germany Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 8: Germany Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 9: Germany Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 10: Germany Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 11: France Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 12: France Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 13: France Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 14: France Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 15: Italy Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 16: Italy Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 17: Italy Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 18: Italy Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 19: Spain Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 20: Spain Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 21: Spain Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 22: Spain Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 23: UK Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 24: UK Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 25: UK Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 26: UK Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 27: Europe Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 28: Europe Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 29: Europe Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 30: Europe Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 31: Japan Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 32: Japan Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 33: Japan Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 34: Japan Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Figure 35: Global Non-Small Cell Lung Cancer Market Size ($mn), 2016 - 2024
Figure 36: Global Non-Small Cell Lung Cancer Product Sales ($mn), 2016 - 2024
Figure 37: Global Non-Small Cell Lung Cancer Market Share by Drugs (%), 2019
Figure 38: Global Non-Small Cell Lung Cancer Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll